Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 351 - 360 of 411

Selected Filters:
1 August 2021

HIV prevention options during pregnancy and breastfeeding – what’s in the pipeline?

Slide presentation given at HIVR4P 2021 providing a broad overview of HIV prevention options for pregnant and breastfeeding populations.

Research

Document
1 March 2021

Test-And-Prevent Analysis: Evaluation of a Pilot Program Linking Clients With Negative HIV Test Results to Pre-exposure Prophylaxis in Zimbabwe

A journal article appearing in Global Health: Science and Practice supporiting clinics offering PrEP to clients receiving negative results to HIV tests.

Research, Testing

Document
1 February 2021

MTN-025

Archived from the MTN website before it was taken down. Primary Objectives Characterize the safety profile associated with the open-label use of the dapivirine (25 mg) vaginal matrix ring (VR) in women Characterize adherence to the open-label use of the dapivirine VR (25 mg) in women Study Summary MTN-025, the HIV Open-label Prevention Extension (HOPE)…

Research

25 January 2021

Evaluating, Scaling up and Enhancing Strategies for Supporting PrEP Continuation and Effective Use

The Prevention Product Manager (PMM) a joint partnership between AVAC and the Clinton Health Access Initiative (CHAI) and Jhpiego convened think tanks to discuss options for defining and measuring PrEP continuation. Recommendations from the think tank included modifications to current PrEP indicators, recognizing that a single definition of correct or effective use might not be…

Research, Monitoring & Evaluation, Service Delivery

Document
1 November 2020

What is CHOICE?

An overview of the CHOICE project

Demand Creation/Marketing, Research, Service Delivery

Document
15 September 2020

Plan 4 PrEP: Étape 3: Scénarios de Déploiement

Cette boîte à outils a été développée et utilisée par le Consortium OPTIONS pour soutenir la planification de l'introduction de la PrEP orale pour la prévention du VIH au Kenya, au Zimbabwe et en Afrique du Sud. Cette boîte à outils est conçue pour aider les utilisateurs d'autres pays à planifier l'introduction et le déploiement…

Research, Normative Guidance/Policies, Service Delivery

Document
15 September 2020

Plan 4 PrEP: Étape 2: Paysage du Projet de la PrEP Orale

Cette boîte à outils a été développée et utilisée par le Consortium OPTIONS pour soutenir la planification de l'introduction de la PrEP orale pour la prévention du VIH au Kenya, au Zimbabwe et en Afrique du Sud. Cette boîte à outils est conçue pour aider les utilisateurs d'autres pays à planifier l'introduction et le déploiement…

Research, Service Delivery

Document
15 September 2020

Plan 4 PrEP: Étape 1: Analyse de la Situation

Cette boîte à outils a été développée et utilisée par le Consortium OPTIONS pour soutenir la planification de l'introduction de la PrEP orale pour la prévention du VIH au Kenya, au Zimbabwe et en Afrique du Sud. Cette boîte à outils est conçue pour aider les utilisateurs d'autres pays à planifier l'introduction et le déploiement…

Financing & Costing, Research, Monitoring & Evaluation, Service Delivery, Supply Chain Management

Document
8 September 2020

Prevention Market Manager Project Summary

The Prevention Market Manager (PMM) is a collaboration between AVAC and the Clinton Health Access Initiative, funded by the Bill & Melinda Gates Foundation. This summary document provides a brief overview of PMM's goals, accomplishments, and learnings.

Research, Service Delivery

Document
23 June 2020

Listening to Young Women in Kenya and South Africa to Inform Multipurpose “2-in-1” Products for HIV and Pregnancy Prevention

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women's perspectives on future MPT in a clinical study of three placebo MPT products.

Research

Document